Xceleron (Chapter 11)
Accelerator mass spectrometry to deliver ultra-sensitive analytical solutions for drug development.
Launch date
Market cap
-
Enterprise valuation
AUD15—22m (Dealroom.co estimates Feb 2012.)
Germantown Maryland (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
£2.0m | Early VC | ||
£2.0m | Series B | ||
N/A | Early VC | ||
N/A | $100k | Grant | |
$2.4m | Early VC | ||
N/A | Acquisition | ||
Total Funding | AUD12.0m |
Related Content
Recent News about Xceleron (Chapter 11)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.